CHARACTERISTICS OF CYSTIC FIBROSIS IN THE KRASNODAR REGION ACCORDING TO A EUROPEAN REGISTER FOR 2011
https://doi.org/10.25207/1608-6228-2014-7-77-83
Abstract
Creation of the Russian register of patients with cystic fibrosis and participation in the program European register is essential for patients in the region and in the country. Result of creating and analyzing annual data register should be the understanding of the following fundamental epidemiological indicators: number of patients, including deaths, number, patient age, their sex distribution. Analysis of the register of patients showed that the proportion of children and adolescents dominates adults (58 children and 14 adults), the average age of the patients below the other regions of the country and the world. Clinical-laboratory features of cystic fibrosis in the Krasnodar region showed an increase in complications of the disease and Pseudomonas aeruginosa infection with age. Total number of mutations have been identified 7, which was 75%. Results register landmark adoption of adequate institutional, medical and social measures when working with patients suffering from cystic fibrosis.
About the Authors
M. M. Khachiyan
GbUZ Children’s regional clinical hospital QC
Russian Federation
Russian Federation
Department of clinical pharmacology.
350063, Victory square, 1; tel. 8 (861) 262-54-64
E. I. Kondratieva
KubGMU Russian ministry of health; Medical genetics research center
Russian Federation
Department of pediatrics neonatology rate CPP and PPP KubGMU; Scientific advisory department of cystic fibrosis.
Russian Federation
Department of pediatrics neonatology rate CPP and PPP KubGMU; Scientific advisory department of cystic fibrosis.
350063, Krasnodar, Sedina street, 4; 115478, Moscow, Moskvorech’e street, 1
S. A. Krasovsky
Institute of pulmonology, FMbA
Russian Federation
Laboratory of cystic fibrosis Institute of pulmonology, FMbA.
Russian Federation
Laboratory of cystic fibrosis Institute of pulmonology, FMbA.
105077, Moscow, 11Parkovaya, 32
A. V. Chernyak
Institute of pulmonology, FMbA
Russian Federation
Russian Federation
Laboratory of cystic fibrosis Institute of pulmonology, FMbA.
105077, Moscow, 11Parkovaya, 32
E. I. Kleshenko
GbUZ Children’s regional clinical hospital QC; KubGMU Russian ministry of health
Russian Federation
Department of clinical pharmacology ChRCH; Department of pediatrics neonatology rate CPP and PPP KubGMU.
Russian Federation
Department of clinical pharmacology ChRCH; Department of pediatrics neonatology rate CPP and PPP KubGMU.
350063, Victory square, 1; tel. 8 (861) 262-54-64; 350063, Krasnodar, Sedina street, 4
V. Y. Brisin
GbUZ Children’s regional clinical hospital QC
Russian Federation
Department of clinical pharmacology.
Russian Federation
Department of clinical pharmacology.
350063, Victory square, 1; tel. 8 (861) 262-54-64
References
1. Кусова З. А., Каширская Н. Ю., Капранов Н. И. Неонатальный скрининг на муковисцидоз // Медицинская генетика. – 2010. – Т. 9. – С. 36–40.
2. Гинтер Е. К., Капранов Н. И., Н. В. Петрова. Муковисцидоз // Генетика бронхолегочных заболеваний. – М., 2010. – C. 51–78.
3. Красовский С. А., Никонова В. С., Каширская Н. Ю., Кондратьева Е. И., Черняк А. В., Капранов Н. И., Амелина Е. Л., Шерман В. Д., Самойленко В. А., Воронкова А. Ю., Шабалова Л. А., Симонова О. И., Усачева М. В., Черников В. В. Клинико-генетическая, микробиологическая и функциональная характеристика больных муковисцидозом Москвы и Московской области // Вопросы современной педиатрии. – 2013. – № 1. – С. 17–23.
4. Голубцов В. И., Рукавичкин Д. В., Морданов С. В., Куцев С. И. Редкие мутации гена CFTR у больных муковисцидозом в Краснодарском крае // Медицинская генетика. – М., 2007. – Т. 6. № 9. – С. 15–19.
5. Голубцов В. И., Рукавичкин Д. В., Шадрин С. А. Варианты молекулярно-генетического полиморфизма муковисцидоза у больных в Краснодарском крае // Фундаментальные исследования Академия естествознания. – М., 2004. – № 1. – С. 46–47.
6. Муковисцидоз / Под ред. Н. И. Капранова, Н. Ю. Каширской. – М.: МЕДПРАКТИКА-М, 2014. – 672 с.
7. Муковисцидоз. Современные достижения и актуальные проблемы: Методические рекомендации. 4-е изд., перераб. и доп / Под ред. Н. И. Капранова, Н. Ю. Каширской. – М., 2011. – 124 с.
8. Ягудина Р. И., Проценко М. В., Мисикова Б. Б. Лекарственное обеспечение в России. – 2011. – № 2. – С. 72–81.
9. ECFS patient registry. Annual Data Report. 2008–2009 www. ecfs. eu].
10. Cystic fibrosis registry of ireland annual report 2010. Woodview house, University college Dublin Belfield, Dublin 4, Ireland. www. cfri. ie.
11. ECFS patient registry. annual data report. 2008–2009. www. ecfs. eu.
12. Cystic fibrosis foundation, patient registry 2010. Annual report, cystic fibrosis foundation, Bethesda, Md, USA, 2011. www. cff. org,
13. UK CF registry. Annual data report 2009. Cystic fibrosis trust 2011. www. cftrust. org. uk.
14. UK CF registry. An. data report 2010. Cystic fibrosis trust 2012. www. cftrust. org. uk.
15. Canadian cystic fibrosis patient data registry report 2010. www. cysticfibrosis. ca.
16. Cystic fibrosis in Australia 2009. 12th. An. report from the australian cystic fibrosis data registry. www. cysticfibrosisaustralia.
17. Pitt james j. Newborn screening // Clin. biochem. rev. – 2010. – May. Vol. 31 (2). – Р. 57–68.
18. Castellani C., Southern K. W., brownlee K. et al. European best practice guidelines for cystic fibrosis neonatal screening // J. cystic fibrosis. – 2009. – Vol. 8. – P. 153–173.
Review
For citations:
Khachiyan M.M., Kondratieva E.I., Krasovsky S.A., Chernyak A.V., Kleshenko E.I., Brisin V.Y. CHARACTERISTICS OF CYSTIC FIBROSIS IN THE KRASNODAR REGION ACCORDING TO A EUROPEAN REGISTER FOR 2011. Kuban Scientific Medical Bulletin. 2014;(7):77-83. (In Russ.) https://doi.org/10.25207/1608-6228-2014-7-77-83
Views:
324
Email this article 